We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Reduction of Topical Anesthetic Onset Time Using Ultrasound

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00126932
Recruitment Status : Completed
First Posted : August 5, 2005
Last Update Posted : December 27, 2007
Information provided by:

Study Description
Brief Summary:
Children ages 3-7 who are undergoing blood drawing receive either standard care, topical medicine for numbing (LMX4), or the study intervention which utilizes ultrasound to speed the onset of LMX4 from 30 minutes to 5 minutes. The child's pain with the blood drawing procedure is evaluated.

Condition or disease Intervention/treatment Phase
Pain Device: SonoPrep Phase 4

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 70 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Reduction of Topical Anesthetic Onset Time Using Ultrasound: A Randomized Controlled Trial Prior to Venipuncture in Young Children
Study Start Date : October 2004
Estimated Study Completion Date : December 2004
Arms and Interventions

Outcome Measures

Primary Outcome Measures :
  1. pain associated with venipuncture

Secondary Outcome Measures :
  1. safety
  2. skin effects
  3. tolerability

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   3 Years to 7 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Ages 3-7, requiring venipuncture

Exclusion Criteria:

  • Emergent procedure
  • Allergy to lidocaine or sodium lauryl sulfate
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00126932

United States, Connecticut
CT Children's Medical Center
Hartford, Connecticut, United States, 06106
Sponsors and Collaborators
Connecticut Children's Medical Center
Principal Investigator: William T. Zempsky, MD CT Children's Medical Center
More Information

ClinicalTrials.gov Identifier: NCT00126932     History of Changes
Other Study ID Numbers: 05-003
First Posted: August 5, 2005    Key Record Dates
Last Update Posted: December 27, 2007
Last Verified: December 2007

Additional relevant MeSH terms:
Central Nervous System Depressants
Physiological Effects of Drugs